TBM100
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Long-term Safety of TIP
Conditions
Long-term Safety of TIP
Trial Timeline
Feb 1, 2013 → Nov 1, 2014
NCT ID
NCT01775137About TBM100
TBM100 is a approved stage product being developed by Novartis for Long-term Safety of TIP. The current trial status is completed. This product is registered under clinical trial identifier NCT01775137. Target conditions include Long-term Safety of TIP.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01775137 | Approved | Completed |
| NCT01519661 | Approved | Completed |